Improving Cancer Immunotherapies through Empirical Neoantigen Selection
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference11 articles.
1. Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer;Sahin;Nature,2017
2. Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing;Yadav;Nature,2014
3. Mass spectrometry profiling of HLA-associated peptidomes in mono-allelic cells enables more accurate epitope prediction;Abelin;Immunity,2017
4. Towards universal structure-based prediction of class II MHC epitopes for diverse allotypes;Bordner;PLoS One,2010
5. Efficient identification of mutated cancer antigens recognized by T cells associated with durable tumor regressions;Lu;Clin. Cancer Res.,2014
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Sensitizing the Efficiency of ICIs by Neoantigen mRNA Vaccines for HCC Treatment;Pharmaceutics;2023-12-29
2. Neoantigens: promising targets for cancer therapy;Signal Transduction and Targeted Therapy;2023-01-06
3. A Universal Antigen-Ranking Method to Design Personalized Vaccines Targeting Neoantigens against Melanoma;Life;2023-01-05
4. The ATLAS™ screening assay reveals distinct CD4+ and CD8+ SARS-CoV-2 antigen response profiles which have implications to Omicron cellular immunity;2022-05-17
5. Neoantigen-based personalized cancer vaccines: the emergence of precision cancer immunotherapy;Expert Review of Vaccines;2021-12-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3